Research Journal of Pharmacy and Technology

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Controlled Clinical Trials:Comparison the efficacy of some Single Topical Scabies Treatment Modalities versus Combined Topical Modalities


Affiliations
1 Family and Community Medicine Department/College of Medicine, Tikrit, University, Iraq
     

   Subscribe/Renew Journal


Background: Scabies is an infectious disease characterized by itching and different types of skin rash. It can be treated successfully by different regimens of anti scabies topical or systemic treatment. Aim: The study is performed to compare the effectiveness of single with combined topical drugs in scabies treatment. Patients and method: The current work is comparative controlled clinical trial study conducted in Tikrit city-Iraq from first of January 2016 to the end of December 2017. Cluster sample chosen from (7) camps of internally displaced population, then (195) scabies patients chosen randomly. Patients were classified to (7) groups. Researcher was applied different modalities of treatment used for first 6 groups and placebo for control (7th group). The data collected and drugs prescribed to patients with instruction. Patients were followed weekly by researcher to assess patient's condition, if they still had scabies criteria after 4 weeks of treatment, the researcher deals with them as treatment failure. Results: The study included 195 scabies patients, from them 50(25.6%) cases were age group (25-> 35). Abdominal lesion is the more frequent presentation of scabies patients in 48(24.6%) cases. The results showed that, the highest cure rate was 28(93.3%) in group 4 ((Permethrine10%+Sulfur10%), then 27(90%) in group 6 (crotamiton10%+Permethrine10%), followed by 26(86.7%) in group 5 (crotamiton10%+Sulfur10%). Conclusion: The study concluded that cure rate in combined topical drugs modalities groups was higher than single topical modalities.

Keywords

Scabies, Clinical Trials, Effectiveness.
Subscription Login to verify subscription
User
Notifications
Font Size


  • Goldust M, Rezaee E, Raghifar R, and Hemayat S. Treatment of scabies: the topical ivermectin vs. permethrin 2.5% cream. Ann Parasitol. 2013, 59(2):79

  • Romani L, Whitfeld MJ, and Koroivueta J. Mass drug administration for scabies control in a population with endemic disease. N Engl J Med 2015;373(24):2305

  • Fitzgerald D, Kevitt FA, and Reid A. Treatment of close contacts of people with scabies for preventing re-infestation or spread of infestation in contacts (Protocol). Cochrane Collaboration and published in The Cochrane Library 2012,7. http://www.thecochranelibrary.com

  • Alsamarai AM. Frequency of scabies in Iraq: survey in dermatology clinic. The Journal of Infection in Developing Countries 2009, 3:789.

  • Les Roberts. IRC: Mortality in Eastern DRC-Results from Five Mortality Studies. IRC Health Unit, 2000.

  • Ishii N. Guideline for the diagnosis and treatment of scabies in Japan (second edition). Journal of Dermatology 2008; 35: 378.

  • Biele M, Campori G, Colombo R, Giorgio G, Frascione P and Sali R. Efficacy and tolerability of a new synergized pyrethrins thermofobic foam in comparison with benzyl benzoate in the treatment of scabies in convicts: the ISAC study (Studio Della scabbia in ambiente carcerario). Journal of the European Academy of Dermatology and Venereology 2006, 20(6):717.

  • Walton SF, Choy JL, and Bonson A. Genetically distinct dog-derived and human-derived Sarcoptes scabiei in scabies-endemic communities in northern Australia. Am J Trop Med Hyg 1999, 61(4):542

  • Hoy WE, White AV, and Dowling A. Post-streptococcal glomerulonephritis is a strong risk factor for chronic kidney disease in later life. Kidney Int 2012, 81(10):1026.

  • Hay RJ, Steer AC, Chosidow O, and Currie BJ. Scabies: A suitable case for a global control initiative. Curr Opin Infect Dis 2013, 26(2):107.

  • Walker GJ, and Johnstone PW. Interventions for treating scabies. Cochrane Database Syst Rev. 2000, (3):CD000320

  • Amer M, and el-Gharib I. Permethrin versus crotamiton and lindane in the treatment of scabies. Int J Dermatol 1992, 31(5):357.

  • Usha V, and Gopalakrishnan NTV. A comparative study of oral ivermectin and topical permethrin cream in the treatment of scabies. J Am Acad Dermatol 2000, 42:236

  • Zargari O, Golchai J, and Sobhani A. Comparison of the efficacy of topical 1% lindane vs 5% permethrin in scabies: a randomized, double-blind study. Indian J Dermatol Venereol Leprol 2006, 72(1):33.

  • Amerio P, Capizzi R, and Milani M. Efficacy and tolerability of natural synergised pyrethrins in a new thermo labile foam formulation in topical treatment of scabies: a prospective, randomised, investigator-blinded, comparative trial vs permethrin cream. Eur J Dermatol 2003;13:69.

  • Strong M, and Johnstone P.W. Interventions for treating scabies. Cochrane Database Syst Rev. 2007;(3):CD000320

  • Mounsey KE, McCarthy JS, and Walton SF. Scratching the itch: new tools to advance understanding of scabies. Trends Parasitol 2013; 29 (1): 35.

  • Singalavanija S, Limpongsanurak W, and Soponsakunkul S. A comparative study between 10 per cent sulfur ointment and 0.3 per cent gamma benzene hexachloride gel in the treatment of scabies in children. J Med Assoc Thai 2003 Aug;86 Suppl 3:531

  • Gaulti PV, Singh K. A family based study on the treatment of scabies with benzyle benzoate and sulpher ointment. Indian J Dermatol Venereol Leprol 1978, 44: 275.

  • Brooks PA, and Grace RF. Ivermectin is better than benzyl benzoate for childhood scabies in developing countries. J Paediatr Child Health 2002;38(4):40

  • Glaziou P, Cartel JL, Alzieu P, Briot C, Moulia-Pelat JP, and Martin PM. Comparison of ivermectin and benzyl benzoate for treatment of scabies. Trop Med Parasitol 1993;44(4):331.

  • Schenone H, Prieto R, Lobos M, Fabres P, and Beresi R. Treatment of scabies with a dermatological lotion of decamethrin at 0.02%. Study in 127 patients by the use of 2 therapeutic regimens [Tratamiento de la sarna con loción dermatológica de decametrina al 0,02% estudio en 127 pacientes mediante la utilización de dos esquemas terapéuticos]. Boletin Chileno de Parasitologia1986;41(1‐2):3.

  • Chouela EN, Abeldano AM, Pellerano G, Forgia M, Papale RM, and Garsd A. Equivalent therapeutic efficacy and safety of ivermectin and lindane in the treatment of human scabies. Archives of Dermatology 1999;135(6):652.

  • Hengge UR, Currie BJ, Jäger G, Lupi O, and Schwartz RA. Scabies: a ubiquitous neglected skin disease. Lancet Infect Dis 2006; 6(12):769.

  • Ronni WMD., Batya B and Davidovici MD. Emergency Dermatology Cambridge Medicine (Hardcover). 1st edition. 17 Jan 2011:12.

  • Mila-Kierzenkowska C, Woźniak A, Krzyżyńska-Malinowska E, Kałużna L, Wesołowski R, Poćwiardowski W, and Owcarz M. Comparative Efficacy of Topical Pertmehrin, Crotamiton and Sulfur Ointment in Treatment of Scabies. J Arthropod Borne Dis 2017 Mar; 11(1): 5.

  • Pourhasan A, Goldust M, Rezaee E. Treatment of scabies, permethrin 5% vs. crotamiton 10% cream. Ann Parasitol 2013, 59( 3): 143.

  • Roos TC, Roos S, Merk HF, Bickers DR. Pharmacotherapy of ectoparasitic infections. Drugs 2001, 61:1067.

  • Meinking TL. Infestations. Curr Probl Dermatol 1999, 11: 101.

  • Karthikeyan K. Treatment of scabies: newer perspectives. Postgrad Med J 2005, 81(951):7.

  • Chosidow O. Scabies and pediculosis: neglected diseases to highlight Clinical Microbiology and Infection 2012, 18(4): 101

  • Muhammad AK, Muhammad Y, and Muhammad WS. Comparative Therapeutic Efficacy of Permethrin, Benzyl benzoate and Sulfur in the treatment of Scabies Patients. IJAVMS 2009, 3(1):45.

  • Andrews RM, McCarthy J, Carapetis JR, and Currie DJ. Skin disorders, including pyoderma, scabies, and tinea infections. Pediatr Clin North Am 2009, 56: 1421.

  • Sunderkötter C, Feldmeier H, Fölster-Holst R. S1-Leitlinie zur Diagnostik und Therapie der Skabies - Kurzfassung. J Dtsch Dermatol Ges 2016:78.

  • Dressler C, Rosumeck S, Sunderkötter C, Niklas Werner R, and Nast A. The Treatment of Scabies: A Systematic Review of Randomized Controlled Trials. Dtsch Arztebl Int 2016, 113(45): 757.


Abstract Views: 238

PDF Views: 0




  • Controlled Clinical Trials:Comparison the efficacy of some Single Topical Scabies Treatment Modalities versus Combined Topical Modalities

Abstract Views: 238  |  PDF Views: 0

Authors

Nisreen M. Ibraheem
Family and Community Medicine Department/College of Medicine, Tikrit, University, Iraq

Abstract


Background: Scabies is an infectious disease characterized by itching and different types of skin rash. It can be treated successfully by different regimens of anti scabies topical or systemic treatment. Aim: The study is performed to compare the effectiveness of single with combined topical drugs in scabies treatment. Patients and method: The current work is comparative controlled clinical trial study conducted in Tikrit city-Iraq from first of January 2016 to the end of December 2017. Cluster sample chosen from (7) camps of internally displaced population, then (195) scabies patients chosen randomly. Patients were classified to (7) groups. Researcher was applied different modalities of treatment used for first 6 groups and placebo for control (7th group). The data collected and drugs prescribed to patients with instruction. Patients were followed weekly by researcher to assess patient's condition, if they still had scabies criteria after 4 weeks of treatment, the researcher deals with them as treatment failure. Results: The study included 195 scabies patients, from them 50(25.6%) cases were age group (25-> 35). Abdominal lesion is the more frequent presentation of scabies patients in 48(24.6%) cases. The results showed that, the highest cure rate was 28(93.3%) in group 4 ((Permethrine10%+Sulfur10%), then 27(90%) in group 6 (crotamiton10%+Permethrine10%), followed by 26(86.7%) in group 5 (crotamiton10%+Sulfur10%). Conclusion: The study concluded that cure rate in combined topical drugs modalities groups was higher than single topical modalities.

Keywords


Scabies, Clinical Trials, Effectiveness.

References